Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Opioids: FDA Actions May Silence Call For Moratorium On Approvals

Mar 27 2019

• By Brenda Sandburg

Opioids - 3D Image

Related Content

Initiator Or Facilitator? Gottlieb Reflects On First Year As Head Of US FDA

May 12 2018

New Opioids: FDA Should Ditch 'Product-Specific Approach,' Science Report Says

Jul 14 2017

Long-Term Opioid Efficacy Studies Will Take Years, Gottlieb Says

Mar 01 2019

Public Citizen: US FDA Deliberately Excluded Risk Committee From Dsuvia Panel To Get Positive Vote

Oct 19 2018

Opioids, Old Initiatives Dominate FY 2020 US FDA Funding Increase

Mar 18 2019

Opioid Policy At US FDA To Become 'More Forceful,' Gottlieb Says

May 24 2017

Dsuvia Approval May Be Followed By New Opioid Review Paradigm At FDA

Nov 02 2018

Opana ER Should Come Off The US Market, FDA Tells Endo

Jun 09 2017

Opioid Sponsors Enter 2019 At A Crossroads

Dec 31 2018

Related Companies

Endo, Inc.

Talphera, Inc.

Nektar Therapeutics

Additional Topics

United States FDA Regulation Drug Review BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window